Add to ORKGA phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI
Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy fo...
Purpose To determine the efficacy of consolidation chemotherapy (CC) with docetaxel and cisplatin (D...
Background: A combination of docetaxel (T) and capecitabine (X) showed synergistic effects in precli...
Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung can...
phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic no...
Objective: It is important to identify optimal regimens of cisplatin-based, third-generation che-mot...
to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esop...
Back Ground: Non small cell lung cancer (NSCLC) constitutes about 75-80 % of all lung cancer cases. ...
Lung cancer remains the leading cause of cancer-related death worldwide with an estimated 900 000 ne...
To evaluate the maximum tolerated dose (MTD) of docetaxel (DCT) and cisplatin (DDP) concurrently wit...
Purpose: To determine the efficacy of consolidation chemotherapy (CC) with docetaxel and cisplatin ...
publisher学位の種類：医学 学位授与年月日：平成18年3月22日 主査：福岡, 正博 教授 報告番号：乙第519号 学内授与番号：医第904号 NDL書誌ID：00000827212
PurposeTo evaluate whether cisplatin-free chemotherapy (docetaxel and gemcitabine [DG]) provides a c...
Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung c...
The phase III PROCLAIM study evaluated overall survival (OS) of concurrent pemetrexed-cisplatin and ...
Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy fo...
Purpose To determine the efficacy of consolidation chemotherapy (CC) with docetaxel and cisplatin (D...
Background: A combination of docetaxel (T) and capecitabine (X) showed synergistic effects in precli...
Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung can...
phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic no...
Objective: It is important to identify optimal regimens of cisplatin-based, third-generation che-mot...
to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esop...
Back Ground: Non small cell lung cancer (NSCLC) constitutes about 75-80 % of all lung cancer cases. ...
Lung cancer remains the leading cause of cancer-related death worldwide with an estimated 900 000 ne...
To evaluate the maximum tolerated dose (MTD) of docetaxel (DCT) and cisplatin (DDP) concurrently wit...
Purpose: To determine the efficacy of consolidation chemotherapy (CC) with docetaxel and cisplatin ...
publisher学位の種類：医学 学位授与年月日：平成18年3月22日 主査：福岡, 正博 教授 報告番号：乙第519号 学内授与番号：医第904号 NDL書誌ID：00000827212
PurposeTo evaluate whether cisplatin-free chemotherapy (docetaxel and gemcitabine [DG]) provides a c...
Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung c...
The phase III PROCLAIM study evaluated overall survival (OS) of concurrent pemetrexed-cisplatin and ...
Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy fo...
Purpose To determine the efficacy of consolidation chemotherapy (CC) with docetaxel and cisplatin (D...
Background: A combination of docetaxel (T) and capecitabine (X) showed synergistic effects in precli...